We attended the 8th Annual ISMPP Meeting in April 2012 in Baltimore and asked attendees and speakers what they thought were the key motivations for health economics and outcomes researchers working together with medical publications professionals?
Three times as much per-capita healthcare spending as the UK, five times as many CT scans as Germany, twice as much spending in McAllen as El Paso, Texas – what’s going on? Americans are consuming more medicine than is good for them…and evidently getting no healthier than people in other countries who spend and consume far less. But why?
In today’s world of hotel-room crystal meth labs and designer drugs from ‘head shops’, why can’t our best and brightest scientific minds create a life-saving vaccine on target and on time?
With so much warning of the HIN1 flu pandemic, why don’t governments and the pharma industry have enough vaccine in time for this flu season? As Dr Dennis Gross explains, for vaccines, the process defines the product. Change the process and you might lose clinical efficacy. The processes for vaccine production – even in 2009 – are fraught with sometimes more art than science.
Getting a drug approval, reimbursement, and access to markets is a long journey, but we are not alone. The focus on this year’s ISPOR EU annual conference was on health technology assessment in different countries. Is an international appraisal system likely in the near future?
One of the best outcomes of our ever-shrinking world is the opportunity to meet colleagues from other countries, to learn their best practices, share ‘war stories’ of failed attempts, and garner new ideas for solutions in our respective home countries. ISPOR held its annual meeting in Paris, France last week, with a focus on health technology assessment processes worldwide.
In recent rounds of the US healthcare debate, ‘rational debate’ seems to have been replaced with scare tactics, in the mainstream media at least. The UK healthcare system recently came under heavy criticism by the anti-reform lobby.
The American public still has surprisingly few details about the proposed legislation for healthcare reform. In this knowledge vacuum, hyperbole and political fighting rush in.
Overhauling the American health insurance system – a Herculean task to be sure, and the debate rages on through the summer months. I have my own strong opinions on this topic, but I am a bit surprised by the vehement response it has evoked among my fellow citizens.
Abstract submission deadlines
Here we present abstract submission deadlines for international medical and health care conferences and meetings. Please note that dates were correct at time of sending this email; HOC cannot be responsible for any amendments.